Andy Lundin, Author at Hematology Advancements

Advances in Flow Cytometry for Hematology Research

Posted by Andy Lundin | Jun 28, 2024 | Research Updates |

Flow cytometry is critical for hematology, allowing for detailed cell population analysis, disease diagnostics, and treatment monitoring.

Posted by Andy Lundin | Jun 28, 2024 | Treatment Advances |

Monoclonal antibodies offer precise mechanisms to attack cancer cells, improving patient outcomes and minimizing side effects.

Posted by Andy Lundin | Jun 28, 2024 | Innovations |

Recent advancements in gene therapy have revolutionized the treatment of hemophilia, particularly hemophilia A and B.

In hematology, multidisciplinary care teams are transforming patient care by combining diverse expertise to improve treatment outcomes.

Partnerships between academic institutions, healthcare providers, and pharma companies are key to advance hematology research and treatment.